[The Cyberknife: experience of centre OSCAR-Lambret].
In June 2007, the CyberKnife has been implemented at Centre Oscar-Lambret in Lille. The program has been developed around specific clinical indications: head and neck reirradiation, liver. Early results are presented. The system includes several way of repositioning fixed targets and tracking moving targets with breathing. With each way, there is a dedicated tool for the quality control.
Lacornerie
T
T
Cyberknife Nord-Ouest, département universitaire de radiothérapie, centre Oscar-Lambret, 59000 Lille, France.
Mirabel
X
X
Lartigau
E
E
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000465:Algorithms; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002173:Cancer Care Facilities; D006528:Carcinoma, Hepatocellular / Q000601:surgery*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000601:surgery; D000068818:Cetuximab; D015179:Colorectal Neoplasms; D004867:Equipment Design; D005260:Female; D005602:France; D006258:Head and Neck Neoplasms / Q000601:surgery*; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009068:Movement; D009364:Neoplasm Recurrence, Local / Q000601:surgery; D016609:Neoplasms, Second Primary / Q000601:surgery; D019047:Phantoms, Imaging; D011786:Quality Control; D016634:Radiosurgery / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D012119:Respiration; D019233:Retreatment; D012371:Robotics / Q000295:instrumentation / Q000379:methods*; D055815:Young Adult
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab